Table 1 Clinical and biochemical characteristics of primary HTG and control groupsa
Primary HTG | Control | p | |
|---|---|---|---|
N = 73 | N = 90 | ||
Age, years | 56.4 ± 12.0 | 53.5 ± 16.2 | 0.210 |
Males, n (%) | 58 (79.4) | 45 (50.0) | 0.000 |
Body mass index, kg/m2 | 27.6 ± 2.35 | 26.6 ± 3.25 | 0.044 |
Total cholesterol, mg/dL | 264 ± 48.0 | 196 ± 34.1 | 0.000 |
Triglycerides, mg/dL | 654 (550–810) | 63.0 (49.7–74.0) | 0.000 |
HDL cholesterol, mg/dL | 40.1 ± 10.5 | 55.2 ± 12.6 | 0.000 |
Glucose, mg/dL | 100 ± 16.1 | 91.3 ± 12.7 | 0.000 |
Hb1Ac (%) | 5.6 (5.3–6.15) | 5.3 (5.1–5.5) | 0.000 |
Diabetes, n (%) | 18 (24.7) | 2 (2.3) | 0.000 |
Hypertension, n (%) | 31 (42.5) | 13 (14.4) | 0.000 |
Cardiovascular disease, n (%) | 11 (15.1) | 3 (3.3) | 0.005 |
APOE genotype (%) | 0.000 | ||
ε2- ε2 | 0 | 0 | |
ε2- ε3 | 19.7 | 0 | |
ε3- ε3 | 57.7 | 100 | |
ε3- ε4 | 16.9 | 0 | |
ε4- ε4 | 1.4 | 0 | |
ε4- ε2 | 4.2 | 0 |